ArticleExperimental hematology & oncology2023

DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study.

Stefano Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.